NasdaqGS - Nasdaq Real Time Price USD

Quince Therapeutics, Inc. (QNCX)

Compare
1.6000
-0.0400
(-2.44%)
At close: January 30 at 4:00:01 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
167,900.0000
103,910.0000
133,228.0000
189,466.0000
Total Liabilities Net Minority Interest
82,816.0000
3,317.0000
14,642.0000
17,204.0000
Total Equity Gross Minority Interest
85,084.0000
100,593.0000
118,586.0000
172,262.0000
Total Capitalization
98,513.0000
100,593.0000
118,586.0000
172,262.0000
Common Stock Equity
85,084.0000
100,593.0000
118,586.0000
172,262.0000
Capital Lease Obligations
385.0000
453.0000
1,161.0000
446.0000
Net Tangible Assets
3,787.0000
94,693.0000
118,586.0000
172,262.0000
Working Capital
67,868.0000
90,679.0000
97,451.0000
120,866.0000
Invested Capital
98,513.0000
100,593.0000
118,586.0000
172,262.0000
Tangible Book Value
3,787.0000
94,693.0000
118,586.0000
172,262.0000
Total Debt
13,814.0000
453.0000
1,161.0000
446.0000
Share Issued
42,973.2150
36,136.4800
30,074.4120
29,543.2220
Ordinary Shares Number
42,973.2150
36,136.4800
30,074.4120
29,543.2220
12/31/2020 - 5/9/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers